Since 1996, 16 states have passed laws legalizing medical use of marijuana, and other states are considering such laws. With little scientific evidence available on whether these fast-changing laws lead to increased illicit adolescent marijuana use (AMU), the issue is now largely a matter of debate. Recently, using data from two national surveys, we showed that states with medical marijuana laws (MML) had significantly higher prevalence of adolescent (Wall et al., 2011) and adult marijuana use (Cerda et al., in press) than other states. The results underscore the importance of further research on MML and AMU, but they do not resolve the debate~ doing so requires explaining the higher AMU we found in states with MML. We propose to investigate four alternative explanations: (a) passage of MML directly increases AMU~ (b) passage of MML indirectly increases AMU, mediated by more favorable attitudes and/or increased availability~ (c) MML and AMU are associated because higher use and more favorable attitudes already characterize states that pass MML~ or (d) a reciprocal process exists, such that states with higher use and more favorable attitudes pass MML, which then further increase the risk for AMU. We will conduct the study using time series data from >1,000,000 adolescents collected annually since 1991 in the Monitoring the Future (MTF) survey. Due to the careful consistency in methods (e.g., procedures, questionnaires) across the years, MTF is the largest dataset available with relevant information on MML and AMU, including potential mediators of key interest, including attitudes related to marijuana (e.g., disapproval~ perceived risk), and perceived marijuana availability. Throughout the study, new data will be added on changes in state MML, and from the additional ~47,000 students surveyed yearly in the MTF. Data will be analyzed using state-of-the-art statistical methods (multilevel regression modeling with poststratification). We will examine yearly state MML and AMU, testing within-state trends relative to national trends, and explore varying time lags. Analyses will incorporate individual-level adolescent attitudes and perceived availability as potential mediators, and variables defined at the state level (e.g., population attitudes towards marijuana, state demographic composition, marijuana arrest rates) from Census and other data sources as potential determinants of MML passage. Further, we will explore whether variations in state MML (e.g., what the laws permit) influence the results, whether gender, SES and race/ethnicity moderate the relationship between MML and AMU, and whether relationships are specific to marijuana or generalize to other substances. The investigative team includes experts from Columbia University, University of Michigan, and a RAND/NBER expert on MML, building on pre-existing collaborations. NIDA PA 11-230 encourages research on MML. Information from the study will be scientifically exciting and have enormous public health significance.

Public Health Relevance

Preventing adolescent marijuana use is a major interest of NIDA (see NIDA 2010 Strategic Plan), but little is known about whether medical marijuana laws lead to increased adolescent marijuana use, leaving the debate about the relationship of these laws to teen marijuana use controversial and not evidence-based. The proposed study will analyze data, by state, from yearly national surveys of adolescents conducted since 1991 (now totaling over 1,000,000 adolescents) to provide this much-needed information. The findings will inform the prevention efforts of health scientists, policy-makers, and the general public in terms of laws and public health education campaigns.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Social Sciences and Population Studies Study Section (SSPS)
Program Officer
Deeds, Bethany
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York State Psychiatric Institute
New York
United States
Zip Code
Sarvet, Aaron L; Hasin, Deborah (2016) The natural history of substance use disorders. Curr Opin Psychiatry 29:250-7
Carliner, Hannah; Delker, Erin; Fink, David S et al. (2016) Racial discrimination, socioeconomic position, and illicit drug use among US Blacks. Soc Psychiatry Psychiatr Epidemiol 51:551-60
Martins, Silvia S; Mauro, Christine M; Santaella-Tenorio, Julian et al. (2016) State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug Alcohol Depend 169:26-32
Hasin, Deborah S; Kerridge, Bradley T; Saha, Tulshi D et al. (2016) Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry 173:588-99
Hasin, Deborah S; Grant, Bridget (2016) NESARC Findings on Increased Prevalence of Marijuana Use Disorders-Consistent With Other Sources of Information. JAMA Psychiatry 73:532
Kim, June H; Santaella-Tenorio, Julian; Mauro, Christine et al. (2016) State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers. Am J Public Health 106:2032-2037
Hasin, Deborah S; Wall, Melanie; Keyes, Katherine M et al. (2015) Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2:601-8
Kerridge, Bradley T; Saha, Tulshi D; Chou, S Patricia et al. (2015) Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. Drug Alcohol Depend 156:47-56
Keyes, Katherine M; Smith, George Davey; Koenen, Karestan C et al. (2015) The mathematical limits of genetic prediction for complex chronic disease. J Epidemiol Community Health 69:574-9
Hasin, Deborah S; Saha, Tulshi D; Kerridge, Bradley T et al. (2015) Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry 72:1235-42

Showing the most recent 10 out of 15 publications